Abstract
The Dutch on-the-road driving test is a standardized test, conducted on a public highway in actual traffic. Participants are instructed to drive for 100-km, while maintaining a steady lateral position and constant speed (95 km/h). Standard Deviation of Lateral Position (SDLP) is the primary outcome measure of the test. This review summarizes the results of 30 years of Dutch on-the-road driving research applying this test. Many central nervous system (CNS)-drugs show dose-dependent impairment on the driving test, expressed in significantly elevated SDLP values relative to placebo. This review discusses several determinants of drug-related driving impairment, including those related to the drug, its use, driver demographics, and the environment. Implications for study design, and limitations of the current methodology are discussed, as well as future challenges to improve the methodology. Overall, the on-the-road driving test has proven to be a reliable and sensitive test to assess the potential effects of CNS drugs on driving ability.
Keywords: Driving, safety, SDLP, on-the-road test, CNS-drugs, anxiolytics, hypnotics, triazolam, flurazepam, benzodiazepines, PLACEBO, sleepiness, methylphenidate, neurobehavioral, tolerance
Current Psychopharmacology
Title: Thirty Years of Dutch Drugs and Driving Research: Strengths and Limitations of the On-The-Road Highway Driving Test and Future Challenges
Volume: 1
Author(s): Joris C. Verster and Thomas Roth
Affiliation:
Keywords: Driving, safety, SDLP, on-the-road test, CNS-drugs, anxiolytics, hypnotics, triazolam, flurazepam, benzodiazepines, PLACEBO, sleepiness, methylphenidate, neurobehavioral, tolerance
Abstract: The Dutch on-the-road driving test is a standardized test, conducted on a public highway in actual traffic. Participants are instructed to drive for 100-km, while maintaining a steady lateral position and constant speed (95 km/h). Standard Deviation of Lateral Position (SDLP) is the primary outcome measure of the test. This review summarizes the results of 30 years of Dutch on-the-road driving research applying this test. Many central nervous system (CNS)-drugs show dose-dependent impairment on the driving test, expressed in significantly elevated SDLP values relative to placebo. This review discusses several determinants of drug-related driving impairment, including those related to the drug, its use, driver demographics, and the environment. Implications for study design, and limitations of the current methodology are discussed, as well as future challenges to improve the methodology. Overall, the on-the-road driving test has proven to be a reliable and sensitive test to assess the potential effects of CNS drugs on driving ability.
Export Options
About this article
Cite this article as:
C. Verster Joris and Roth Thomas, Thirty Years of Dutch Drugs and Driving Research: Strengths and Limitations of the On-The-Road Highway Driving Test and Future Challenges, Current Psychopharmacology 2012; 1 (1) . https://dx.doi.org/10.2174/2211556011201010097
DOI https://dx.doi.org/10.2174/2211556011201010097 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Utility of Assessing Thiopurine S-methyltransferase Polymorphisms Before Azathioprine Therapy
Current Drug Metabolism Inhibition of Product Template (PT) Domain of Aflatoxin Producing Polyketide Synthase Enzyme of Aspergillus parasiticus
Letters in Drug Design & Discovery Outfielders Playing in the Infield: Functions of Aging-Associated "Nuclear" Proteins in the Mitochondria
Current Molecular Medicine What Western Pharmacists Need to Know About Traditional Chinese Medicine; A Canadian Perspective
Current Traditional Medicine The Multiple Facets of Hematopoietic Stem Cells
Current Neurovascular Research Characteristics of Self-Defining Memories in Middle-Aged and Older Adults
Current Aging Science Platelet Alpha- and Beta- Secretase Activities are not Significantly Affected by Dementia or Mild Cognitive Impairment in Swedish Patients
Current Alzheimer Research Chest Pain in Children
Current Pediatric Reviews Association of Cerebrospinal Fluid Adiponectin Levels With Cerebral Glucose Metabolism In Mild Cognitive Impairment: A Pilot Study
Current Alzheimer Research Dehydroepiandrosterone (DHEA): A Steroid with Multiple Effects. Is there Any Possible Option in the Treatment of Critical illness?
Current Medicinal Chemistry Patent Selections:
Recent Patents on CNS Drug Discovery (Discontinued) Recent Advances in the Diagnosis and Therapy of Primary Adrenal Insufficiency
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Evidences of Monomer, Dimer and Trimer of Recombinant Human Cyclophilin A
Protein & Peptide Letters Novel Pathways in the Treatment of Major Depression: Focus on the Glutamatergic System
Current Pharmaceutical Design Psychosocial Predictors of Relapse Among Patients with Alcohol Problems
Current Drug Abuse Reviews The Palmitoylethanolamide Family: A New Class of Anti-Inflammatory Agents ?
Current Medicinal Chemistry Cytokines in Dementias
Current Drug Targets - Inflammation & Allergy Plant Secondary Metabolites in Cancer Chemotherapy: Where are We?
Current Pharmaceutical Biotechnology Radiosyntheses using Fluorine-18: The Art and Science of Late Stage Fluorination
Current Topics in Medicinal Chemistry Novel Metals and Metal Complexes as Platforms for Cancer Therapy
Current Pharmaceutical Design